Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734237 · ClinicalTrials.gov registry record · Phase 4
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
A Phase 4 study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Active
- Registry status
- Phase 4
- Development phase
- 15,448
- Enrollment target
NCT03734237 is a Phase 4 study that is active but no longer recruiting, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 15,448 participants.
The verdict
NCT03734237, a Phase 4 study, is active but no longer recruiting, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 15,448 participants
- Enrollment target
Study Summary
A total of 18,000 eligible subjects (or 6,000 subject distributed evenly between the 3 study arms) will be enrolled. Eligible subjects will be randomized in 1:1:1 (cell-culture-based vaccine, the recombinant vaccine, or the egg-based vaccine) over four influenza seasons (2018-2019, 2019-2020, 2020-2021, and 2021-2022).
Interventions
- BIOLOGICAL Egg based influenza vaccines
- BIOLOGICAL Recombinant influenza vaccines
- BIOLOGICAL Cell-culture based influenza vaccines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,448 participants |
| Start Date | 2018-11-06 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03734237
The ClinicalTrials.gov registry entry for NCT03734237 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 15,448 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Egg based influenza vaccines is the first listed.
NCT03734237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03734237 about?
NCT03734237 is a clinical study titled "A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD". A total of 18,000 eligible subjects (or 6,000 subject distributed evenly between the 3 study arms) will be enrolled. Eligible subjects will be randomized in 1:1:1 (cell-culture-based vaccine, the recombinant vaccine, or the egg-based vaccine) over four influenza seasons (2018-2019, 2019-2020, 2020-2...
What is the current status of trial NCT03734237?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 15,448 participants. The study started on 2018-11-06. Estimated completion is 2026-06-30.
What interventions are being tested in trial NCT03734237?
The interventions under investigation include: Egg based influenza vaccines (BIOLOGICAL), Recombinant influenza vaccines (BIOLOGICAL), Cell-culture based influenza vaccines (BIOLOGICAL).
Who is sponsoring clinical trial NCT03734237?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.